High materiality8/10
BeOne Medicines price target raised to $459 from $450 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital raises ONC target to $459 from $450; current price $341.10.
- Target $459 (from $450); price $341.10; RBC Capital
Key facts
- 01
Target: $459
- 02
Posted price: $341.1
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.